Eagle Pharmaceuticals (EGRX) Tops Q4 EPS by 7c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Eagle Pharmaceuticals (EGRX) Tops Q4 EPS by 7c, Revenues Beat

Eagle Pharmaceuticals (EGRX) PT Raised to $66 at RBC Capital

March 1, 2019 6:44 AM EST

RBC Capital analyst Randall Stanicky raised the price target on Eagle Pharmaceuticals (NASDAQ: EGRX) to $66.00 (from $64.00) while maintaining a Outperform rating following results.

"EGRX reported 4Q this morning that brought few material updates," Stanicky commented. "Notably, the coming weeks/months should bring... More